On June 27, 2025, the California Senate amended Assembly Bill (AB) 1415 to add back in a reporting requirement for management services organizations (MSOs) undergoing a sale of a material amount of assets or change of...more
7/3/2025
/ Acquisitions ,
California ,
Health Care Providers ,
Hedge Funds ,
New Legislation ,
Private Equity ,
Proposed Amendments ,
Proposed Legislation ,
Regulatory Oversight ,
Regulatory Requirements ,
Reporting Requirements
The California Assembly amended Assembly Bill (AB) 1415 on April 24, 2025. The bill aims to bring healthcare investments by private equity groups and hedge funds more fully into the scope of the California Office of Health...more
5/5/2025
/ Acquisitions ,
California ,
Government Agencies ,
Health Care Providers ,
Healthcare ,
Healthcare Facilities ,
Healthcare Reform ,
Legislative Agendas ,
New Legislation ,
Private Equity ,
Reporting Requirements
California legislators recently introduced AB 1460, which would prohibit prescription drug manufacturers from engaging in discriminatory practices aimed at providers participating in the 340B drug pricing program (covered...more
3/14/2025
/ Anti-Discrimination Policies ,
California ,
Competition ,
Health Care Providers ,
Legislative Agendas ,
New Legislation ,
Pharmaceutical Industry ,
Pharmacies ,
Prescription Drugs ,
Regulatory Requirements ,
Section 340B ,
State Legislatures
Find this week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick...more
Find this week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick...more
2/13/2025
/ Audits ,
Department of Health and Human Services (HHS) ,
Enforcement Actions ,
FOIA ,
Health Care Providers ,
Healthcare ,
HRSA ,
Medicare ,
Pharmaceutical Industry ,
Prescription Drugs ,
Regulatory Oversight ,
Section 340B
Find this week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick...more
2/5/2025
/ Class Action ,
Enforcement Actions ,
FOIA ,
Health Care Providers ,
Healthcare ,
HRSA ,
Medicare ,
Medicare Advantage ,
Pharmaceutical Industry ,
Pharmacies ,
Regulatory Requirements ,
Section 340B
Find this week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick...more